BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 104 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.44 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $7,000 | -96.4% | 900 | -96.2% | 0.00% | -98.1% |
| Q1 2019 | $193,000 | +0.5% | 23,741 | 0.0% | 0.05% | -50.0% |
| Q4 2018 | $192,000 | +6.1% | 23,741 | 0.0% | 0.11% | +86.0% |
| Q3 2018 | $181,000 | +23.1% | 23,741 | -7.8% | 0.06% | +9.6% |
| Q2 2018 | $147,000 | +19.5% | 25,741 | 0.0% | 0.05% | +10.6% |
| Q1 2018 | $123,000 | -2.4% | 25,741 | 0.0% | 0.05% | -4.1% |
| Q4 2017 | $126,000 | – | 25,741 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management II, LLC | 6,071,142 | $38,430,000 | 18.43% |
| RTW INVESTMENTS, LP | 4,078,895 | $25,819,000 | 9.72% |
| VHCP Management, LLC | 1,155,104 | $7,312,000 | 7.86% |
| RA Capital Management | 2,989,795 | $18,925,000 | 2.68% |
| DLD Asset Management, LP | 1,258,700 | $7,967,000 | 2.61% |
| Avoro Capital Advisors LLC | 1,631,502 | $10,327,000 | 2.09% |
| Ghost Tree Capital, LLC | 1,150,000 | $7,280,000 | 1.75% |
| GREAT POINT PARTNERS LLC | 725,000 | $4,589,000 | 0.94% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,237,734 | $20,495,000 | 0.84% |
| Baker Brothers Advisors | 10,963,944 | $69,402,000 | 0.68% |